VivoSeq
Other

Atropine

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Atropine is an early-stage landscape with 0 programs across 1 company. The most active players are Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Z

Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

18

clinical trials

Completed12 · 67%
Unknown status5 · 28%
Recruiting1 · 6%

Clinical Trials

Trial Activity

18 trials

Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Recruiting·KKubota Vision Inc.·N/A·NCT06034379·45 enrolled
Sublingual Atropine Bioequivalence by Route of Administration (SABER)
Completed·Biomedical Advanced Research and Development Authority·Phase 1·NCT06366087·46 enrolled
A Study of Inhaled Atropine Sulfate in Healthy Adults
Completed·MMicroDose Defense Products L.L.C.·Phase 1·NCT00947596·18 enrolled
Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants
Completed·SState University of New York at Buffalo·Phase 4·NCT01819064·60 enrolled
Use of Atropine in Tredmill Stress Testing
Completed·HHaEmek Medical Center, Israel·Phase 3·NCT00623207·103 enrolled
Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET
Completed·MMayo Clinic·Phase 3·NCT00583323·60 enrolled
The Effects of Low Dose Atropine on Choroidal Thickness
Completed·SState University of New York College of Optometry·Phase 4·NCT03544827·36 enrolled
The Response to Atropine Drops (RAD) Study
Completed·OOhio State University·Phase 1·NCT05199597·30 enrolled
Short Term Refractive and Ocular Parameter Changes After Topical Atropine
Completed·TTaipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation·N/A·NCT03839888·96 enrolled
Sublingual vs IV Atropine Bioavailability Study
Completed·Biomedical Advanced Research and Development Authority·Phase 1·NCT04290039·15 enrolled
The Influence of Atropine on Choroidal Thickness
Completed·SState University of New York College of Optometry·Phase 4·NCT03158142·32 enrolled
Trial Comparing Daily Atropine Versus Weekend Atropine
Completed·JJaeb Center for Health Research·Phase 4·NCT00094614·168 enrolled
Pharmacokinetics of Atropine Oral Gel
Completed·UUniversity of Utah·Phase 1·NCT05164367·10 enrolled
Effect of Atropine on Pupil Size and Quality of Vision
Unknown status·HHe Eye Hospital·N/A·NCT06071260·40 enrolled
Study of Atropine Therapeutic Effect on Myopic Progression
Unknown status·LLitePharmTech Co., Ltd.·Phase 3·NCT05529056·472 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)